Latest Commercialization News

Patrys Limited has expanded its clinical pipeline by acquiring Reliis Pty Ltd, gaining a proprietary injectable formulation of Quetiapine aimed at the large and underserved delirium market. This strategic move balances Patrys’ portfolio with a near-term pharmaceutical asset alongside its biologics program.

Syntara Limited has successfully completed Phase 1a trials for its topical anti-fibrotic drug SNT-9465, demonstrating dose-dependent target engagement and safety, and is now progressing to an innovative Phase 1b study in hypertrophic scars.

88 Energy Limited updates on its Alaska-based Project Phoenix, announcing a fully funded horizontal well and extended flow test scheduled for Q3 2026, backed by joint venture partner Burgundy Xploration LLC. The project is positioned for first production as early as 2027 amid a resurgence in North Slope activity.

Delorean Corporation has teamed up with Paper Australia (Opal) to explore a renewable energy project at the Maryvale Paper Mill, aiming to convert organic waste into green gas and electricity through anaerobic digestion.

Synertec has secured a pivotal contract to supply its zero-emission Powerhouse system to Shell QGC’s Coal Seam Gas operations in Queensland, marking a significant step in industrial decarbonisation.

Electro Optic Systems has completed its acquisition of the UK-based Interceptor business, marking a strategic expansion into the AUKUS market and enhancing its counter-drone technology portfolio.

CSIRO has sold about half its shares in Chrysos Corporation through a block trade, reducing its stake by roughly 9%, yet remains a committed substantial shareholder with a six-month escrow on its retained shares.

Temple & Webster Group has reported a record FY25 revenue of $601 million, marking a 21% increase year-on-year, alongside a 43% rise in EBITDA. The company is confidently progressing towards its ambitious $1 billion mid-term revenue target.

Cleo Diagnostics has secured a $1.7 million R&D tax refund, strengthening its cash reserves to $5.75 million as it advances toward a pivotal US clinical trial and FDA submission for its ovarian cancer test.

First Graphene has locked in a 12-month exclusive global license to develop and sell graphene-enhanced carbon paste, a breakthrough material already boosting solar cell efficiency and cutting costs.

HyTerra Limited has partnered with GeoKiln Energy Innovation to pioneer a groundbreaking test of engineered geologic hydrogen production, aiming to accelerate commercialization in this emerging energy sector.

Parkway Corporate Limited has marked its transition to profitability in FY25, unveiling a transformative Queensland Brine Management Complex project set to redefine waste brine processing in Australia’s coal seam gas sector.